About Bioline  All Journals  Testimonials  Membership  News

Malawi Medical Journal
College of Medicine, University of Malawi and Medical Association of Malawi
ISSN: 1995-7262
Vol. 19, No. 1, 2007, pp. 37-38
Bioline Code: mm07012
Full paper language: English
Document type: Research Article
Document available free of charge

Malawi Medical Journal, Vol. 19, No. 1, 2007, pp. 37-38

 en Is sulphadoxine-pyrimethamine (SP) still useful as the first-line antimalarial drug in Malawi or it must be quickly withdrawn from the antimalarial repertoire?
Nkhoma, Standwell


In recent years our efforts to control malaria successfully have been severely hampered by widespread and highlevel resistance to front-line antimalarial drugs. In 1993,Malawi had to replace chloroquine (CQ) with sulphadoxinepyrimethamine (SP) as the first-line antimalarial owing to unacceptably high rates of CQ failure. Thirteen years after this change in treatment policy, Malawi is faced with a scenario that calls for yet another switch to a different first-line antimalarial.


© Malawi Medical Journal
Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil